Literature DB >> 15777161

G-protein-coupled receptor signaling, RGS proteins, and lymphocyte function.

John H Kehrl1.   

Abstract

The positioning of lymphocytes in immune organs and the migration of lymphocytes that occurs during normal immune surveillance and following immune activation depends on appropriate signaling through receptors that couple to heterotrimeric G-proteins. In addition other mediators that affect lymphocyte function, such as histamine, purine nucleosides, C5A, prostaglandins, leukotrienes, serotonin, epinephrine, opioids, and certain phospholipids, also signal through G-protein-coupled receptors (GPCRs). Downstream of heterotrimeric G-proteins are a limited number of downstream effectors, which, in turn, activate a large number of other signaling molecules, many of which are shared with other signaling pathways, such as those activated by antigen receptors, coreceptors, and adhesion receptors. Crucial to signaling through GPCRs are finely developed regulatory systems, which control the activation of heterotrimeric G-proteins and their interactions with their immediate downstream effectors. This review will focus on the overall importance of GPCR signaling in lymphocyte function and an upstream regulatory system present in lymphocytes, which fine tunes heterotrimeric G-protein signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15777161     DOI: 10.1615/critrevimmunol.v24.i6.20

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  12 in total

1.  Beta-agonist-associated reduction in RGS5 expression promotes airway smooth muscle hyper-responsiveness.

Authors:  Zhao Yang; Philip R Cooper; Gautam Damera; Indranil Mukhopadhyay; Hyeseon Cho; John H Kehrl; Reynold A Panettieri; Kirk M Druey
Journal:  J Biol Chem       Date:  2011-01-29       Impact factor: 5.157

2.  The effect of opioids on the development of postoperative intra-abdominal adhesions.

Authors:  Amir Khorram-Manesh; Jalal Vahedian Ardakani; Hamid Reza Behjati; Gunnar Nylund; Dick Delbro
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

3.  Class I odorant receptors, TAS1R and TAS2R taste receptors, are markers for subpopulations of circulating leukocytes.

Authors:  Agne Malki; Julia Fiedler; Kristina Fricke; Ines Ballweg; Michael W Pfaffl; Dietmar Krautwurst
Journal:  J Leukoc Biol       Date:  2015-01-26       Impact factor: 4.962

Review 4.  Chemoattractant receptor signaling and the control of lymphocyte migration.

Authors:  John H Kehrl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  Transcriptomic analysis of the woodchuck model of chronic hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Yongmei Ji; A Leonardo Iniguez; Bruce Taillon; David C Swinney; Palanikumar Ravindran; Donavan T Cheng; Hans Bitter; Uri Lopatin; Han Ma; Klaus Klumpp; Stephan Menne
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

Review 6.  Genes, tolerance and systemic autoimmunity.

Authors:  Ram P Singh; Richard T Waldron; Bevra H Hahn
Journal:  Autoimmun Rev       Date:  2011-11-30       Impact factor: 9.754

7.  Thromboxane receptor signaling is required for fibronectin-induced matrix metalloproteinase 9 production by human and murine macrophages and is attenuated by the Arhgef1 molecule.

Authors:  John M Hartney; Claire E Gustafson; Russell P Bowler; Roberta Pelanda; Raul M Torres
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

Review 8.  Non-traditional roles of G protein-coupled receptors in basic cell biology.

Authors:  Xin Zhang; Ulrike S Eggert
Journal:  Mol Biosyst       Date:  2013-04-05

9.  Rgs13 constrains early B cell responses and limits germinal center sizes.

Authors:  Il-Young Hwang; Kyung-Sun Hwang; Chung Park; Kathleen A Harrison; John H Kehrl
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  The loss of Gnai2 and Gnai3 in B cells eliminates B lymphocyte compartments and leads to a hyper-IgM like syndrome.

Authors:  Il-Young Hwang; Chung Park; Thuyvi Luong; Kathleen A Harrison; Lutz Birnbaumer; John H Kehrl
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.